Pages
All Departments
Let's get Social
Copyright Here. All rights reserved.
BYWWW.NEJM.ORGJuly 13, 2017
Background Riociguat, a soluble guanylate cyclase stimulator, has been shown in a phase 2 trial to be beneficial in the treatment of pulmonary arterial hypertension.